BACKGROUND: Vascular risk factors contribute to motor decline in the elderly persons. We investigated the relationship between lipid-lowering drugs (LLDs) use and decline in walking speed (WS) in older adults. METHODS: Data on 4,009 community-dwelling men and women, aged ≥65 years at baseline, are drawn from the Dijon (France) center of the Three-City study. "Fast" WS was assessed over 6 m at baseline and at 4, 6, 8, and 10 years of follow-up. Mixed linear models were used to determine the relationship between LLDs and change in WS over the follow-up. RESULTS: At baseline, 1,295 (32%) participants used LLDs (statins, n = 643; fibrates, n = 652); mean fast WS was 152.9cm/s and not significantly different between LLDs users and nonusers. In models adjusted for age, sex, cholesterol level, and other covariates, WS decline was 25% slower in LLDs users (difference with nonusers: 0.58cm/s/y, 95% CI: 0.30, 0.86; p < .001). Both fibrates and statins were associated with slower decline, but only the effect of statins was robust in analyses that took missing values into account. The beneficial effect was more pronounced in those on LLDs continuously over the follow-up. CONCLUSION: Fast WS declined less in those on LLDs, suggesting that the effect of LLDs, statins in particular, extend beyond that on cardiovascular disease in the elderly persons. However, these effects were modest and their clinical relevance is unclear.
BACKGROUND: Vascular risk factors contribute to motor decline in the elderly persons. We investigated the relationship between lipid-lowering drugs (LLDs) use and decline in walking speed (WS) in older adults. METHODS: Data on 4,009 community-dwelling men and women, aged ≥65 years at baseline, are drawn from the Dijon (France) center of the Three-City study. "Fast" WS was assessed over 6 m at baseline and at 4, 6, 8, and 10 years of follow-up. Mixed linear models were used to determine the relationship between LLDs and change in WS over the follow-up. RESULTS: At baseline, 1,295 (32%) participants used LLDs (statins, n = 643; fibrates, n = 652); mean fast WS was 152.9cm/s and not significantly different between LLDs users and nonusers. In models adjusted for age, sex, cholesterol level, and other covariates, WS decline was 25% slower in LLDs users (difference with nonusers: 0.58cm/s/y, 95% CI: 0.30, 0.86; p < .001). Both fibrates and statins were associated with slower decline, but only the effect of statins was robust in analyses that took missing values into account. The beneficial effect was more pronounced in those on LLDs continuously over the follow-up. CONCLUSION: Fast WS declined less in those on LLDs, suggesting that the effect of LLDs, statins in particular, extend beyond that on cardiovascular disease in the elderly persons. However, these effects were modest and their clinical relevance is unclear.
Entities:
Keywords:
Epidemiology.; Gait; Lipid-lowering drugs; Motor function; Statins
Authors: Kristina Tiainen; Mikko Hurme; Antti Hervonen; Tiina Luukkaala; Marja Jylhä Journal: J Gerontol A Biol Sci Med Sci Date: 2010-04-26 Impact factor: 6.053
Authors: Mary McGrae McDermott; Jack M Guralnik; Philip Greenland; William H Pearce; Michael H Criqui; Kiang Liu; Lloyd Taylor; Cheeling Chan; Leena Sharma; Joseph R Schneider; Paul M Ridker; David Green; Maureen Quann Journal: Circulation Date: 2003-02-11 Impact factor: 29.690
Authors: Andrea Z LaCroix; Shelly L Gray; Aaron Aragaki; Barbara B Cochrane; Anne B Newman; Charles L Kooperberg; Henry Black; J David Curb; Philip Greenland; Nancy F Woods Journal: J Gerontol A Biol Sci Med Sci Date: 2008-04 Impact factor: 6.053
Authors: Jay Giri; Mary M McDermott; Philip Greenland; Jack M Guralnik; Michael H Criqui; Kiang Liu; Luigi Ferrucci; David Green; Joseph R Schneider; Lu Tian Journal: J Am Coll Cardiol Date: 2006-02-09 Impact factor: 24.094
Authors: Shelly L Gray; Aaron K Aragaki; Michael J LaMonte; Barbara B Cochrane; Charles Kooperberg; Jennifer G Robinson; Nancy F Woods; Andrea Z LaCroix Journal: J Am Geriatr Soc Date: 2012-11-23 Impact factor: 5.562
Authors: Vincent C T Mok; Wynnie W M Lam; Yu Hua Fan; Adrian Wong; Ping Wing Ng; Tak Hon Tsoi; Vincent Yeung; Ka Sing Wong Journal: J Neurol Date: 2009-03-01 Impact factor: 4.849
Authors: Joseph V Agostini; Mary E Tinetti; Ling Han; Gail McAvay; Joanne M Foody; John Concato Journal: J Am Geriatr Soc Date: 2007-03 Impact factor: 5.562
Authors: Rebecca M Henderson; Laura Lovato; Michael E Miller; Roger A Fielding; Tim S Church; Anne B Newman; Thomas W Buford; Marco Pahor; Mary M McDermott; Randall S Stafford; David S H Lee; Stephen B Kritchevsky Journal: J Gerontol A Biol Sci Med Sci Date: 2016-03-17 Impact factor: 6.053
Authors: Wei-Hsuan Lo-Ciganic; Subashan Perera; Shelly L Gray; Robert M Boudreau; Janice C Zgibor; Elsa S Strotmeyer; Julie M Donohue; Clareann H Bunker; Anne B Newman; Eleanor M Simonsick; Douglas C Bauer; Suzanne Satterfield; Paolo Caserotti; Tamara Harris; Ronald I Shorr; Joseph T Hanlon Journal: J Am Geriatr Soc Date: 2014-12-23 Impact factor: 5.562
Authors: Laurette van Boheemen; Susan E Tett; Evelien Sohl; Jacqueline G Hugtenburg; Natasja M van Schoor; G M E E Peeters Journal: Drugs Aging Date: 2016-06 Impact factor: 3.923
Authors: Kari Luotola; Satu Jyväkorpi; Annele Urtamo; Kaisu H Pitkälä; Mika Kivimäki; Timo E Strandberg Journal: Age Ageing Date: 2020-02-27 Impact factor: 10.668